Use and Impact of Positron Emission Tomography/Computed Tomography Prior to Salvage Radiation Therapy in Men with Biochemical Recurrence After Radical Prostatectomy: A Scoping Review.

Published on Feb 23, 2021in European Urology Oncology
· DOI :10.1016/J.EUO.2021.01.007
Luca F. Valle3
Estimated H-index: 3
(UCLA: University of California, Los Angeles),
Luca F. Valle8
Estimated H-index: 8
(UCLA: University of California, Los Angeles)
+ 6 AuthorsAmar U. Kishan19
Estimated H-index: 19
(UCLA: University of California, Los Angeles)
Sources
Abstract
Abstract Context The use, common findings, and impact of modern molecular positron emission tomography (PET)/computed tomography (CT) imaging prior to salvage radiation therapy (RT) in men with biochemical recurrence after radical prostatectomy (RP) have not been evaluated comprehensively. Objective We performed a scoping systematic review of the literature assessing detection rates, detection patterns, changes in management, as well as changes in patient outcome resulting from molecular PET/CT imaging using three molecular tracers: 18F-fluciclovine, 8Ga prostate-specific membrane antigen (PSMA)-11, and 18F-DCFPyL. Evidence acquisition A computerized bibliographic search of the Medline/PubMed database was carried out from inception to October 1, 2020. We included published reports and abstracts evaluating the utility of 1Fluciclovine, 68Ga-PSMA-11, and 18F-DCFPyL PET in the detection of recurrent disease in the post-RP, pre–salvage RT setting. Outcomes of interest were extracted and tabulated, and existing evidence was synthesized qualitatively. Evidence synthesis A total of 45 studies were included in our qualitative synthesis. Detection rates were high across most studies, and there was often a clear relationship between prostate-specific antigen (PSA) level and positive imaging findings. Though limited randomized data are available, there appears to be increased sensitivity with the use of PSMA ligands compared with fluciclovine at low PSA values. Most studies have shown that only one-third to one-half of patients with detected lesions have lesions in the prostatic fossa alone. Management changes occur in nearly 50% of patients undergoing molecular imaging, and biochemical response in patients who undergo molecular PET-based RT planning appears to be statistically superior to the response in patients who undergo conventional imaging -based RT planning alone. High biochemical responses from molecular PET–based salvage RT, ranging from 45% to 94%, did not appear to come at the expense of increased genitourinary or gastrointestinal toxicity. The presence or absence of avid lesions appears to be a strong prognostic factor. Conclusions Molecular PET/CT imaging in the post-RP, pre–salvage RT setting often triggers management changes that result from detecting lesions in locations not typically included in consensus-driven postoperative RT fields. Ongoing trials will assess the benefit of PSMA PET in guiding salvage RT following RP and determine its impact on long-term outcomes. Patient summary We reviewed and reported detection rates, detection patterns, and changes in management resulting from molecular positron emission tomography/computed tomography imaging in men with biochemically recurrent prostate cancer following radical prostatectomy. Prior to the receipt of salvage radiation therapy, molecular tracers targeting prostate-specific membrane antigen appear to be especially sensitive at identifying the place where prostate cancer has come back after surgery, which can help radiation oncologists better target the recurrent disease and potentially improve the rates of cure from prostate cancer in this setting. Future studies will determine whether these imaging tools will change cure rates and side effects, but early results are promising.
📖 Papers frequently viewed together
1 Citations
27 Citations
46 Citations
References70
Newest
#1Kilian Schiller (TUM: Technische Universität München)H-Index: 10
#2Lucia Stöhrer (TUM: Technische Universität München)H-Index: 1
Last. Stephanie E. Combs (TUM: Technische Universität München)H-Index: 34
view all 13 authors...
Abstract Background Many patients experience recurrence of prostate cancer after radical prostatectomy. Objective The aim of this study was to visually analyze typical patterns of lymph node (LN) involvement for prostate cancer (PC) patients with biochemical recurrence after radical prostatectomy and lymphadenectomy by creating a color-coded heat map using gallium-68 prostate-specific membrane antigen positron emission tomography (68Ga-PSMA-PET) imaging. Further, we evaluated which LNs were cove...
6 CitationsSource
1 CitationsSource
#1Claire L Vale (UCL: University College London)H-Index: 25
#2David Fisher (UCL: University College London)H-Index: 23
Last. Jayne F. Tierney (UCL: University College London)H-Index: 55
view all 18 authors...
Summary Background It is unclear whether adjuvant or early salvage radiotherapy following radical prostatectomy is more appropriate for men who present with localised or locally advanced prostate cancer. We aimed to prospectively plan a systematic review of randomised controlled trials (RCTs) comparing these radiotherapy approaches. Methods We used a prospective framework for adaptive meta-analysis (FAME), starting the review process while eligible trials were ongoing. RCTs were eligible if they...
34 CitationsSource
#1Andrew Kneebone (USYD: University of Sydney)H-Index: 29
Last. Maria PearseH-Index: 9
view all 23 authors...
Summary Background Adjuvant radiotherapy has been shown to halve the risk of biochemical progression for patients with high-risk disease after radical prostatectomy. Early salvage radiotherapy could result in similar biochemical control with lower treatment toxicity. We aimed to compare biochemical progression between patients given adjuvant radiotherapy and those given salvage radiotherapy. Methods We did a phase 3, randomised, controlled, non-inferiority trial across 32 oncology centres in Aus...
28 CitationsSource
#1Abhishek A. Solanki (LUC: Loyola University Chicago)H-Index: 11
#2Bital Savir-Baruch (LUC: Loyola University Chicago)H-Index: 13
Last. Jian Q. YuH-Index: 27
view all 44 authors...
Purpose Conventional imaging rarely localizes the site(s) of prostate cancer recurrence in patients undergoing evaluation for salvage radiotherapy (sRT) after radical prostatectomy (RP). XXX (NCTXXX) was a prospective multicenter study investigating the impact of 18F-fluciclovine positron emission tomography/computed tomography (PET/CT) on the management of patients with biochemical recurrence of prostate cancer after curative-intent radiation or RP and negative or equivocal conventional imaging...
2 CitationsSource
#1William A. Hall (MCW: Medical College of Wisconsin)H-Index: 23
#2Eric S. Paulson (MCW: Medical College of Wisconsin)H-Index: 19
Last. Colleen A. Lawton (MCW: Medical College of Wisconsin)H-Index: 61
view all 25 authors...
Purpose In 2009, the Radiation Therapy Oncology Group (RTOG) genitourinary members published a consensus atlas for contouring prostate pelvic nodal clinical target volumes (CTVs). Data have emerged further informing nodal recurrence patterns. The objective of this study is to provide an updated prostate pelvic nodal consensus atlas. Methods and materials A literature review was performed abstracting data on nodal recurrence patterns. Data were presented to a panel of international experts, inclu...
6 CitationsSource
#1Vishesh Agrawal (Cornell University)H-Index: 2
#2Xiaoyue Ma (Cornell University)H-Index: 2
Last. Himanshu Nagar (Cornell University)H-Index: 11
view all 5 authors...
This retrospective study uses data from the National Cancer Database of new cancer diagnoses across the US to examine trends in proportional diagnosis rates and management of patients with high-risk prostate cancer.
Source
#1Noelia Sanmamed (U of T: University of Toronto)H-Index: 3
#2Rachel Glicksman (U of T: University of Toronto)H-Index: 6
Last. Alejandro Berlin (U of T: University of Toronto)H-Index: 17
view all 11 authors...
Abstract Purpose To assess the impact of RTOG-9601 and GETUG-AFU-16 on the routine use of combination androgen deprivation therapy (ADT) with postoperative radiotherapy (PORT) for prostate cancer (CaP). Material and methods Patients with localized CaP treated with radical prostatectomy (RP) and PORT with or without ADT at a comprehensive cancer center from January 2006 to June 2007 (Period 1 = P1), July 2011 to December 2012 (Period 2 = P2), and January 2017 to June 2018 (Period 3 = P3) were inc...
1 CitationsSource
#1Nika GuberinaH-Index: 1
#2P. HetkampH-Index: 1
Last. Axel WetterH-Index: 20
view all 15 authors...
Purpose The aim of this study was to evaluate the detection rate of [68Ga]prostate-specific membrane antigen ([68Ga]PSMA-11) positron emission tomography (PET)/magnetic resonance imaging (MRI) and to compare it with [68Ga]PSMA-11 PET/X-ray computed tomography (CT) in patients with recurrent prostate cancer (PC) after radical prostatectomy.
12 CitationsSource
#1Andrew Scarsbrook (Leeds Teaching Hospitals NHS Trust)H-Index: 29
#2David Bottomley (Leeds Teaching Hospitals NHS Trust)H-Index: 20
Last. Fergus V. Gleeson (University of Oxford)H-Index: 58
view all 18 authors...
Abstract Purpose Early and accurate localisation of lesions in patients with biochemical recurrence (BCR) of prostate cancer may guide salvage therapy decisions. The present study, XXX, aimed to evaluate the impact of 18F-fluciclovine on management of men with BCR of prostate cancer. Methods Men with a first episode of BCR following curative-intent primary therapy were enrolled at 6 UK sites. Patients underwent 18F-fluciclovine PET/CT according to standardised procedures. Clinicians documented m...
14 CitationsSource
Cited By1
Newest
#1Alberto Bossi (Institut Gustave Roussy)H-Index: 33
#2Pierre Blanchard (Institut Gustave Roussy)H-Index: 31
Last. Stefano Fanti (UNIBO: University of Bologna)H-Index: 83
view all 3 authors...
Source